 Research
 Open access
 Published:
Association filtering and generative adversarial networks for predicting lncRNAassociated disease
BMC Bioinformatics volume 24, Article number: 234 (2023)
Abstract
Background
Long noncoding RNA (lncRNA) closely associates with numerous biological processes, and with many diseases. Therefore, lncRNAdisease association prediction helps obtain relevant biological information and understand pathogenesis, and thus better diagnose preventable diseases.
Results
Herein, we offer the LDAF_GAN method for predicting lncRNAassociated disease based on association filtering and generative adversarial networks. Experimentation used two types of data: lncRNAdisease associated data without lncRNA sequence features, and fused lncRNA sequence features. LDAF_GAN uses a generator and discriminator, and differs from the original GAN by the addition of a filtering operation and negative sampling. Filtering allows the generator output to filter out unassociated diseases before being fed into the discriminator. Thus, the results generated by the model focuses only on lncRNAs associated with disease. Negative sampling takes a portion of disease terms with 0 from the association matrix as negative samples, which are assumed to be unassociated with lncRNA. A regular term is added to the loss function to avoid producing a vector with all values of 1, which can fool the discriminator. Thus, the model requires that generated positive samples are close to 1, and negative samples are close to 0. The model achieved a superior fitting effect; LDAF_GAN had superior performance in predicting fivefold crossvalidations on the two datasets with AUC values of 0.9265 and 0.9278, respectively. In the case study, LDAF_GAN predicted disease association for six lncRNAsH19, MALAT1, XIST, ZFAS1, UCA1, and ZEB1AS1and with the top ten predictions of 100%, 80%, 90%, 90%, 100%, and 90%, respectively, which were reported by previous studies.
Conclusion
LDAF_GAN efficiently predicts the potential association of existing lncRNAs and the potential association of new lncRNAs with diseases. The results of fivefold crossvalidation, tenfold crossvalidation, and case studies suggest that the model has great predictive potential for lncRNAdisease association prediction.
Introduction
Biologists first discovered the existence of long noncoding RNA [1] (lncRNA) in 1990s, which opened new doors for biomedical research. Long noncoding RNAs, which are more than 200 nucleotides in length, are involved in numerous biological processes, such as chromatin modification, cell proliferation, and transcriptional regulation [2]. A relationship exists between lncRNA and disease, such that mutations can lead to many diseases, such as lung cancer [3], cardiovascular diseases [4], and neurodegenerative diseases [5]. Therefore, the study of lncRNAdisease association can clarify the functions of lncRNA, and facilitate the prevention, diagnosis and treatment of human diseases. Unfortunately, biological experiments to prove the association between lncRNA and diseases are often costly, and this and time constitute major obstacles. Alternatively, computational methods can efficiently study the association of lncRNA with diseases. Current popular methods of research involve two categories: machine learning and predictive biological networks.
Recently, machine learning is a leading edge as exemplified by bioinformatics. Zhao et al. [6] developed a computational method based on a simple Bayesian classifier of lncRNA association data and a genome that achieved excellent results. However, their classifier requires on negative samples, which affects the model’s performance. Lan et al. [7] integrated multiple data sources of lncRNA and diseases, and used multiple approaches to calculate lncRNA and disease similarity for different data sources. They used a SVM classifier and organized it into a web server LDAP, by feeding RNA sequences into LDAP to make predictions. Biswas et al. [8] offered a method that used a nonnegative decomposition matrix and multiple association data and expression profile data. Their lowrank computational model well described the association between twodimensional matrices. In addition, an idea has been adopted by many studies that diseases or lncRNAs with similar properties may have the same association object. Chen et al [9]. constructed a semisupervised framework, LRLSLDA, based on lncRNA and disease similarity. Advantageous, the semisupervised model did not entirely rely on data labels. Although the method discovered potential associations without negative samples, the model has many parameters, and the choice of parameters will inevitably affect the prediction results. Finally, Chen et al. [10] developed two semantic similaritybased models, LNCSIM1 and LNCSIM2, and organically combined them with the LRLSLDA [9] model, which significantly improved model performance.
Biological networks usually build various association or similarity networks. The most common methods are based on lncRNA diseaseassociation, lncRNA similarity, and disease similarity networks. For example, RWRlncD [11] uses lncRNA functional similarity networks and random wandering (RWR) to make a prediction, but its biggest drawback is that it cannot be applied to disease prediction without known associations. Geng et al. [12] constructed a heterogeneous network of lncRNAs, miRNAs, and diseases to discover potential associations. The greatest advantage of the heterogeneous network is that features of multiple nodes can be fused to make predictions more accurate. Yao et al. [13] constructed a multilayer composite network (LncPriCNet) on multiple interactions data. They used a RWR method to mine potential associations, and LncPriCNet still maintained advantages in the face of insufficient information on lncRNAs due to the support of the multilayer composite network. lncRDNetFlow [14] integrated multiple source networks to predict lncRNA disease associations, and in the absence of known associations.
Both types of methods require lncRNAdisease association data. Because verified biological experimental association data are limited, researchers must use lncRNA expression profiles, tissue specificity, gene location, etc. to predict associations. Li et al. [15] used gene locations to predict the association of lncRNAs with vascular disease. The drawback of their method is that it is limited by gene location information, and because there is no guarantee that the lncRNAs have adjacent genes, even if there are adjacent genes, they are not necessarily associated. Liu et al. [16] proposed using disease and lncRNA expression profiles that can be independent of known lncRNAdisease relationships, but the few associated gene records limit its application.
Recent attention has focused Generative Adversarial Networks (GANs). GANs consist of a generator and a discriminator, which can be trained to generate samples extremely similar to the original data [17]. GANs have no dimensional requirement on the input of the generator, and only require a gradient backpropagation to train the model, avoiding the use of complex Markov chains. This iterative approach has spread to the natural language processing and recommendation system. GANs has the advantage of semisupervised learning. Most of the data in the recommendation system yield only positive feedback, which is ideal for training with semisupervised learning. Currently, many GAN recommendation models have emerged, such as IRGAN [18], GraphGAN [19], PSGAN [20], APL [21], and CFGAN [22]. Numerous studies have shown that these models obtain superior results in the recommendation domain compared to baseline models. In this paper, lncRNAdisease association data and useritem recommendation data have similar properties, i.e., prediction of unknown associations based on known association data. So it is reasonable to assume that for the same sparse lncRNAdisease association data, GANbased association prediction algorithms have significant advantages over supervised learning. Notably, Du et al. [23] offered LDAGAN for lncRNAdisease association prediction. It uses the GumbelSOFTMAX technique to construct separable processes to simulate discrete sampling.
Inspired by LDAGAN and CFGAN. The application of LDAGAN in lncRNA disease association prediction guided our study, but the inability to directly backpropagate gradients during model training also posed many inconveniences. In contrast, CFGAN with realvalued vector adversarial training achieves better prediction results, which provides a new idea for our research. Unlike CFGAN, our model needs to process lncRNA sequence data and obtain effective implicit feature information, so network structures that can extract sequence features need to be introduced in the design of generators and discriminators. Meanwhile, considering the sequence characteristics of lncRNA nucleotide sequences, this paper combined Doc2Vec and fully connected neural network to optimize the generator and discriminator, so that lncRNA sequence features is able to more accurately participate in the generation and determination of lncRNAdisease association. we offer LDAF_GAN, a method for lncRNAassociated disease prediction based on association filtering and GANs. The filtering involves a dot product of the generated results of the generator with real data (retaining the part of the association matrix that corresponds to 1 in real data). Thus LDAF_GAN only focuses on associated data. Negative sampling assumes that values of 0 in the association matrix have no association, and the remaining values have unknown associations. By adding a regular term to the loss function, the generator cannot generate all1 vectors, which ultimately improves the generative power of LDAF_GAN. Experimental results reveal that LDAF_GAN has fivefold crossvalidation AUC values over 91% and tenfold crossvalidation AUC values over 92% on four trial datasets. Further, disease associations for six common lncRNAs predicted by LDAF_GAN reveal that accuracy can achieve 100%, 80%, 90%, 90%, 100%, and 90% for H19, MALAT1, XIST, ZFAS1, UCA1, and ZEB1AS1, respectively.
Methods
Generative adversarial networks
GAN architecture [17] of the LDAF_GAN model, which was built to fit our data, was not based on a fixed structured model, but rather an adversarial framework. The structure of the submodel depended on the type of data. Parameter definitions are listed in Table 1.
Generative network
LDAF_GAN mainly consisted of a generative and discriminative networks. The former was a multilayer, fully connected neural network denoted as \(G(\theta )\). When LDAF_GAN was trained on dataset1, the input was represented as \(G(\theta ,z)\), where \(\theta\) was the parameter of the generator and z the random noise. Next, the output of G was expressed as \(ld\_r_{g}\) (i.e., represents the result of the random noise z input to the generator and then output by the softmax function), which had the same dimension as the noise dimension. When LDAF_GAN was trained on dataset2, the input was represented as \(G(\theta ,\{z, c\_seq\})\), where \(c\_seq\) denoted the lncRNA sequence feature, \(``\{\}''\) denoted the connection noise z, and the lncRNA sequence feature was \(c\_seq\), and the output of G was \(ld\_seq\_r_{g}\).
Discriminative network
Discriminator network was also a multilayer fully connected neural network that had the same input dimensions, but the output dimension was 1. Accordingly, \(D(\phi )\) was used to represent the discriminator, where \(\phi\) was the parameter of the discriminator. In LDAF_GAN, every iteration of the discriminator required the input of real and generated data. The generated data were represented as either \(ld\_r_{g} \bigodot fua\_real\) or \(ld\_seq\_r_{g} \bigodot fua\_real\) (where operation \(``\bigodot ''\) was used for filtering and \(fua\_real\) was consistent with the real data). Then, generated data were fed into the discriminator as either \(D(\phi , G(\theta ,z))\) or \(D(\phi , G(\theta , \{z, c\_seq\}))\). Meanwhile, \(ld\_real\) (\(ld\_real\) represents the Boolean matrix composed of real association data) or \(\{ld\_real,c\_seq\}\) was input to D. Finally, the model give feedback to G by calculating the gap between the generated data and the real data, and the gradient back propagation was adjusted to the G network to generate new data that were closer to the original data distribution.
LncRNA sequence feature extraction
The lncRNA sequence is composed of four nucleotides, “A”, “G”, “C” and “T”. The traditional kmer method obtains the feature of sequences by counting the frequency of nucleotide occurrences. However, the kmer ignores the order of nucleotides, thus we would like to take the nucleotide order into consideration in this study. Firstly, we adopt the idea of kmer to divide the sequence into several substrings of length k; secondly, we adopt the Doc2vec model to obtain the vector expression of each string; finally, these strings are combined vertically into a matrix in order to obtain the features of the sequence. An example is shown in Fig. 1.
LDAF_gan
The submodel LDAF_gan of LDAF_GAN was trained using associated data without lncRNA sequence features. Upon combining the generative and discriminative networks, we completed a generative adversarial network. We followed the common GAN [17] to construct the LDAF_GAN model. The main structure involved generator G and the discriminator D, but for the output of G we employed a simple filtering operation; the final model architecture is shown in Fig. 2.
Following the input of random noise, generator \(G(\theta ,z)\) yielded a matrix of lncRNAdisease association where \(\theta\) was a hyperparameter of G and z denoted noise. The row vector of the matrix represents the likelihood that a particular lncRNA is associated with all diseases, and the column vector represents the likelihood that a disease is associated with all lncRNAs. Each value of matrix was interpreted as the association likelihood of a lncRNA with a predicted disease. Each value of vector was interpreted as the association of an lncRNA with a predicted disease. The softmax function normalized the association between (0,1) to get \(ld\_r_{g}\). Next, filtering (Filtering Unknown Associations, FUA) eliminated the effect of unknown associations on the generated results. The filtering operation is to dot product the output of the generator with the negative sampling matrix of real lncRNAdisease association, and the filtering will retain the values corresponding to the positive and negative samples in the generated results, which makes the discriminator feedback more accurate. After filtering, ld_rg’ is obtained, which was denoted as \(ld\_r_{g} \bigodot fua\_real\). Then, \(ld\_r_{g}'\) was fed into the discriminator together with real data \(ld\_real\) as \(D(\phi , G(\theta ,z))\) and \(D(\phi ,ld\_real)\), and the output value indicated the probability of accuracy. Finally, D was fed back to G, which made adjustments, where G minimized the probability of a false result; the loss function of G was expressed as Eq. (1).
where z denotes the noise vector that obeys the distribution of noisy data \(P_{noise}\). Correspondingly, D improved discriminatory capabilities by maximizing the gap between the real data and the generated data. Thus, the loss function of D was expressed as Eq. (2).
where x denotes the vector of real data, following the real data \(P_{real}\) distribution. G and D were represent in Eq. (3).
LDAF_gan_seq
Submodel LDAF_gan_seq was trained with fused lncRNA sequence data. LDAF_gan_seq differed slightly from LDAF_gan via slightly adjusting G and D network dimensions of LDAF_gan. The overall model is shown in Fig. 3.
Features of lncRNA sequences, mainly composed of “A”, “G”, “C” and “T”, were extracted using the methods mentioned in above. It is worth noting that for lncRNA sequence features, our model specifically constructs a network module in the generator to extract the implicit features of lncRNA sequences, and the same network layer is set in the discriminator, which constitutes the overall model structure of sequence feature processing, lncRNAdisease association generation and discrimination. Random noise was then connected with sequence features as the input of G, which is represented by \(G(\theta ,\{z,c\_seq\})\) (Fig. 2), where \(``\{\}''\) denotes connecting the noise z with the feature \(c\_seq\), and outputting the same dimension as the noise after passing G. Subsequently, the softmax function was used to normalize \(ld\_seq\_r_{g}\), followed by the FUA operation \(ld\_seq\_r_{g} \bigodot fua\_real\), filtering out the unknown association data to get \(ld\_seq\_r_{g}'\). Real data \(ld\_real\) and generated data \(ld\_seq\_r_{g}'\) were fed into D, and the results are expressed as \(D(\phi ,ld\_real)\) and \(D(\phi ,G(\theta ,\{z,c\_seq\}))\), where \(\phi\) is the hyperparameter of D. The output was judged to be the probability of accuracy. The loss function of G in LDAF_GAN was expressed as Eq. (4).
Then, the loss function of D was shown in Eq. (5).
Negative sampling
Sections 1.2 and 1.3 introduce the GANbased LDAF_GAN approach to prediction. The greatest drawback in our approach is the absence of negative samples for the association data. Values of 0 in the matrix do not differentiate between no association and an association waiting to be predicted. In LDAF_GAN, the generation of all1 vectors, which is the same result as the original data after filtering, is meaningless, therein necessitating a negative sampling strategy. Partial negative sampling in the unknown association data (matrix value of 0) gives value to unknown associations, which are denoted as no association. To avoid generating all vectors with values of 1, a regular term is added to the loss function in the training of G. The loss function of G is changed slightly (taking the fused lncRNA sequence feature model as an example), and the loss of G after negative sampling is represented as follows:
where \(x_{li}\) denotes the negative sampling result on the original data and \(\hat{x}_{li}\) is negative sampling result on \(fua\_real\). Considering the associated and unassociated terms in the training process of D, the negative sampling results must be as close to 0 as possible, while the true association is as close to 1 as possible to give feedback information to G. Accordingly, the loss function of D is adjusted as follows:
Model evaluation
To facilitate a comparison between LDAF_GAN and other models, we used fivefold and tenfold crossvalidations. The former divides the samples into five uniformly disjoint parts, one as the test set and the remaining four as the training set. We then conducted five experiments in turn. The latter crossvalidation divided the samples into ten uniformly disjoint parts, one part as the test set and the remaining nine as the training set, and we conducted ten experiments. The AUC was the area enclosed by the curves and axes in the coordinate system, with FPR as the horizontal coordinate and TPR as the vertical coordinate. This was used to evaluate the predictive performance of the model. The AUPR value was the area enclosed by the curve and the axis in the coordinate system, composed of recall as the horizontal coordinate and precision as the vertical coordinate. This evaluated the overall performance of the model, and was calculated as follows:
where TP denoted the probability of positive samples being correctly predicted as positive samples, and FN denoted the probability of positive samples being incorrectly predicted as negative samples. FP denoted the probability of negative samples being incorrectly predicted as positive samples, and TN denoted the probability of negative sample being correctly predicted as negative samples.
Results
Comparison with other stateoftheart methods
Experimental setting and datasets
This experiment was implemented on the PyTorch platform. To demonstrate the performance of the model, LDAF_GAN was applied to four datasets. First, fivefold crossvalidation and tenfold crossvalidation were performed on two publicly available datasets taken from BiGAN [24]: LncRNADisease 2.0 [25] and Lnc2Cancer v2.0 [26]. Further, lncRNADisease 2.0 [25] contained 19,166 lncRNAs and 529 diseases, then 205,959 lncRNAdisease association data were finally obtained; there were 9254 lncRNAdisease associations in the Lnc2Cancer dataset, which contained 2659 lncRNAs and 216 diseases. Second, crossvalidation was performed on our constructed datasets dataset 1 and dataset 2, both of which contained 5213 associations with 1301 lncRNAs and 497 diseases, while there were 1301 corresponding lncRNA sequences in dataset 2 and none in dateset 1 (lncRNA sequence data from the database Refseq [25])).
LncRNADisease dataset comparison experiment
Firstly, we compared several methods, such as BiGAN [24], CNNLDA [26], NBCLDA [29], TILDA [27] and LDAP [7] on the LncRNADisease 2.0 [25] dataset, and the tenfold crossvalidation ROC curves were shown in Fig. 4. Experimental results showed that the LDAF_GAN method on the LncRNADisease dataset was significantly more effective than several other methods, and the AUC value reached about 0.975. The results demonstrated that the semisupervised learning of GAN is very effective for lncRNAdisease association prediction even when only positive samples were available.
Lnc2Cancer dataset comparison experiments
LDAF_GAN was compared with BiGAN [24], CNNLDA [26], NBCLDA [29], TILDA [27] and LDAP [7] on the Lnc2Cancer v2.0 [26] dataset. The AUC value reached 0.915, and ROC curves under tenfold cross validation were shown in Fig. 5. LDAF _GAN achieved the best results among these models, and was second only to BiGAN [25]. However, our model did not utilize lncRNAs or a diseases similarity network, and relied on association data alone. For the prediction of a new lncRNA node, LDAF_GAN only required the lncRNA sequence features without calculating the similarity vector again.
Experiments on all data sets
Finally, LDAF_GAN was crossvalidated on dataset 1 and dataset 2, and then divided into two submodels: LDAF_gan and LDAF_gan_seq. The LDAF_gan model was constructed on dataset 1, while the LDAF_gan_seq model was constructed on dataset 2. The results of LDAF_GAN on both datasets showed that LDAF_GAN predicted well not only the association data without sequence features, but also the multimodal data with fused sequence features. Our fivefold crossvalidation results were shown in Fig. 6, where Fig. 6a showed the results of LDAF_GAN on dataset 1; the average AUC value obtained was 0.926. Figure 6b showed the fivefold crossvalidation results of LDAF_gan_seq on dataset 2, and the average AUC value was 0.928. Figure 6c showed the fivefold crossvalidation results of LDAF_GAN on the LncRNADisease [25] dataset, and Fig. 6d the fivefold crossvalidation results of LDAF_gan on the Lnc2Cancer [26] dataset. Finally, all results of the LDAF_GAN validation on three datasets without lncRNA sequence features were shown in Table 2, including the mean AUC values and mean AUPR values under five and tenfold crossvalidation. LncRNADisease [25] dataset reached an average AUPR value of 0.45, Lnc2Cancer [26] dataset an average AUPR value of 0.15, and our dataset an average AUPR value of 0.15. LDAF_GAN achieved excellent predictions on several datasets, which was initially designed for training on continuous values, and while still achieving excellent predictions on discrete values. The negative sampling strategy used by LDAF_GAN helped the model to selectively generate results close to 0 or 1, thus avoiding misclassification caused by generating all1 vectors.
Case studies
We used lncRNAs H19, MALAT1, XIST, ZFAS1, UCA1, and ZEB1AS1 to verify LDAF_GAN. The two submodels based on LDAF_GAN have two prediction methods, both of which is able to predict the disease associated with a specific lncRNA. Based on LDAF_gan, the known association vector (i.e., the vector containing only 0 and 1) of lncRNA(e.g., H19) is fed into the generator, and after passing through the softmax function, an association vector will be output, whose elements are between (0,1). Disregarding the known associated diseases among them, the topranked corresponding diseases in the predicted associations are selected as the final prediction results. Based on LDAF_gan_seq, a random noise is connected with the sequence features of a certain lncRNA (e.g., ZFAS1) and fed into the trained generator. Finally, an association vector also is output through softmax function, and the topranked diseases are selected as the final prediction result. The predicted disease association on H19, MALAT1, and XIST reached 100\(\%\), 80\(\%\), and 90\(\%\), respectively (based on experimental validations from the Lnc2Cancer [18] database) (Tables 3, 4, 5, respectively). We singled out lncRNA ZFAS1, UCA1, and ZEB1AS1, which were not included in the training data, and used the lncRNA sequence features of ZFAS1, UCA1, and ZEB1AS1 as the input of LDAF_GAN to generate the top 10 ranked diseases. The prediction accuracy value reached 90\(\%\), 100\(\%\), and 90\(\%\), respectively (Table 6, 7, 8, respectively).
Discussion
Our lncRNAassociated disease prediction model LDAF_GAN,which is based on association filtering and Generative Adversarial Networks, fuses lncRNA sequence features to achieve prediction. Compared with several other prediction models, LDAF_GAN is stable and achieves superior performance. As a semisupervised learning GAN, LDAF_GAN achieves good results even when only positive samples are available. In particular, the prediction of new lncRNAs does not require associated data, and the data distribution captured by GAN during training can support the prediction of new nodes. Thus, the method can achieve superior results both on the prediction of the original nodes and the prediction of new nodes. Further, excellent prediction results derives from two key points: filtering and negative sampling. Filtering allows the model to focus only on the parts with known associations, while negative sampling avoids pattern collapse due to the generation of all1 vectors, which are also crucial for training. Finally, case studies show that LDAF_GAN accurately predicts disease associations for lncRNAs with known associations and lncRNA nodes without known associations but with lncRNA sequences. Nevertheless, some future developments may enhance predictions. For example, we adopt a negative sampling strategy, yet there is no guarantee that the negative samples are unassociated, which affects judgment of the model. For diseases, the model performance will be improved once appropriate disease features are incorporated.
Conclusion
LncRNAs play an important role in biological life processes, and discovering potential associations between lncRNAs and diseases facilitates better diagnoses and prevention of diseases. To this end, we offer a method for lncRNAassociated disease prediction based on association filtering and Generating Adversarial Networks, called LDAF_GAN. Experiments use two types of datasets: association data, and association data with fused lncRNA sequence features. Submodel LDAF_gan is useful for cases of only association data. Three association data validate this approach, and the results show that the fivefold crossvalidation AUC values of LDAF_gan are 0.9760, 0.9137 and 0.9265. For data with sequence features, submodel LDAF_gan_seq is applicable. It has an average fivefold crossvalidation AUC value of 0.9278. Validation results from several datasets show that LDAF_GAN can achieve excellent results and high accuracy predictions. LDAF_gan_seq can make predictions in the absence of lncRNAdisease association, which is valuable in the absence of known associations; accurate predictions can be achieved using sequence features of lncRNAs as input. The validation results of LDAF_GAN on two publicly available and our own datasets verify credibility of the model. The correct prediction of most of the top 10 diseases by LDAF_GAN for six lncRNAs demonstrates its effectiveness.
Availability of data and materials
The LDAF_GAN source code is available at https://github.com/ZhonghuaYNNU/LDAF_GAN LncRNADisease v2.0: http://www.rnanut.net/lncrnadisease/index.php/home/info/download. Lnc2Cancer: http://www.biobigdata.net/lnc2cancer/download.html. dataset1: http://www.cuilab.cn/lncrnadisease and http://www.biobigdata.net/lnc2cancer/download.html. dataset2: https://lncipedia.org/ and https://www.ncbi.nlm.nih.gov/refseq/.
Abbreviations
 \(ld\_r_{g}\) :

LDAF_GAN generates data
 \(c\_seq\) :

lncRNA sequence characteristics
 \(ld\_seq\_r_{g}\) :

LDAF_gan_seq generates data
 \(ld\_real\) :

Real data
 \(fua\_real\) :

Data for filtering operations
 \(ld\_r^{'}_{g}\) :

LDAF_gan filtered results
 \(ld\_seq\_r^{'}_{g}\) :

LDAF_gan_seq filtered results
 \(fua\_real\_sample\) :

Filtered data after negative sampling
 \(N\_sample\) :

Number of negative sampling samples
References
Qian X, Zhao J, Yeung PY, Zhang QC, Kwok CK. Revealing lncRNA structures and interactions by sequencingbased approaches. Trends Biochem Sci. 2019;44(1):33–52.
Mercer TR, Dinger ME, Mattick JS. Long noncoding RNAs: insights into functions. Nature Rev Genet. 2009;10(3):155–9.
De Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA. Dd3(pca3), a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62(9):2695–8.
Klattenhoff C, Scheuermann J, Surface L, Bradley R, Fields P, Steinhauser M, Ding H, Butty V, Torrey L, Haas S. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell. 2013;152(3):570–83.
Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, Georges SLI, Kenny PJ, Wahlestedt C. Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feedforward regulation of betasecretase. Nat Med. 2008;14(7):723–30.
Zhao T, Xu J, Liu L, Bai J, Xu C, Xiao Y, Li X, Zhang L. Identification of cancerrelated lncRNAs through integrating genome, regulome and transcriptome features. Mol BioSyst. 2015;11(1):126–36.
Lan W, Li M, Zhao K, Liu J, Wu FX, Pan Y, Wang J. LDAP: a web server for lncRNAdisease association prediction. Bioinformatics. 2016;33(3):458–60.
Ashis Kumer Biswas MK. Inferring disease associations of the long noncoding RNAs through nonnegative matrix factorization. Netw Model Anal Health Inform Bioinform. 2015;4(1):1–17.
Chen X, Yan GY. Novel human lncRNAdisease association inference based on lncRNA expression profiles. Bioinformatics. 2013;29(20):2617–24.
Yan C, Luo C, Ji W, Zhang Y, Dai Q. Constructing lncRNA functional similarity network based on lncRNAdisease associations and disease semantic similarity. Sci Rep. 2015;5:11338.
Sun J, Shi H, Wang Z, Zhang C, Zhou M. Inferring novel lncRNAdisease associations based on a random walk model of a lncRNA functional similarity network. Mol BioSyst. 2014;10(8):2074–81.
Xia G, KaiJian H. Mirnadisease association prediction based on network representation learning method. Appl Res Comput. 2021;38(05):1365–70.
Yao Q, Wu L, Li J, Yang L, Sun A, Li Z, He S, Feng F, Li H, Li Y. Global prioritizing disease candidate lncRNA via a multilevel composite network. Sci Rep. 2017;7:39516.
Zhang J, Zhang Z, Chen Z, Deng L. Integrating multiple heterogeneous networks for novel lncRNAdisease association inference. IEEE/ACM Trans Comput Biol Bioinf. 2019;16(2):396–406.
Jianwei LI, Gao C, Wang YC, Wei MA, Jian TU, Wang JP, Chen ZZ, Kong W, Cui QH. A bioinformatics method for predicting long noncoding RNAS associated with vascular disease. Sci China. 2014;000(008):852–7.
Liu MX, Chen X, Chen G, Cui QH, Yan GY. A computational framework to infer human diseaseassociated long noncoding RNAS. PLoS ONE. 2014;9(1):84408.
Goodfellow I, PougetAbadie J, Mirza M, et al. Generative adversarial nets. Adv Neural Inf Process Syst 2014:2672–2680.
Wang J, Yu L, Zhang W, Gong Y, Xu Y, Wang B, Zhang P, Zhang D. Irgan: a minimax game for unifying generative and discriminative information retrieval models. In: Proceedings of the 40th international ACM SIGIR conference on research and development in information retrieval (2017).
Wang H, Jia W, Wang J, Miao Z, Guo M. Graphgan: graph representation learning with generative adversarial nets. In: The 27th ACM international conference (2017).
Lu S, Dou Z, Xu J, Nie JY, Wen JR. Psgan: a minimax game for personalized search with limited and noisy click data. In: The 42nd international ACM SIGIR conference (2019).
Sun Z, Wu B, Wu Y, Ye Y. APL: adversarial pairwise learning for recommender systems. Expert Syst Appl. 2019;118:573–84.
Chae DK, Kang JS, Kim SW, Lee JT. Cfgan: a generic collaborative filtering framework based on generative adversarial networks. In: The 27th ACM international conference (2018)
Du B, Tang L, Liu L, Zhou W. Predicting LncRNAdisease association based on generative adversarial network. Curr Gene Ther. 2022;22(2):144–51.
Yang Q, Li X. BiGAN: LncRNAdisease association prediction based on bidirectional generative adversarial network. BMC Bioinform 2021;22:357.
O’Leary NA, Wright MW, Brister JR, Ciufo S, Pruitt KD. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucl Acids Res. 2015;44(Database issue):733–45.
Xuan P, Cao Y, Zhang T, Kong R, Zhang Z. Dual convolutional neural networks with attention mechanisms based method for predicting diseaserelated lncRNA genes. Front Genet. 2013;10:416.
Ping P, Wang L, Kuang L, Ye S, Iqbal MFB, Pei T. A novel method for LncRNAdisease association prediction based on an lncRNAdisease association network. IEEE/ACM Trans Comput Biol Bioinform. 2019;16(2):688–93.
Xuan P, Cao Y, Zhang T, Kong R, Zhang Z. Dual convolutional neural networks with attention mechanisms based method for predicting diseaserelated lncRNA genes. Front Genet. 2013;10:416.
Yu J, Ping P, Wang L, Kuang L, Li X, Wu Z. A novel probability model for lncRNAdisease association prediction based on the Naïve Bayesian classifier. Genes. 2018;9(7):345.
Ping P, Wang L, Kuang L, Ye S, Iqbal MFB, Pei T. A novel method for LncRNAdisease association prediction based on an lncRNAdisease association network. IEEE/ACM Trans Comput Biol Bioinform. 2019;16(2):688–93.
Acknowledgements
We would like to thank the the Advanced Computing Center of Yunnan University. Their constructive comments have led to an improved version of the paper.
Funding
This work was supported by the National Natural Science Foundation of China (grant no. 61862067, U1902201), Yunnan Provincial Science and Technology DepartmentYunnan University Double FirstClass Joint Fund Key Projects (grant no. 2019FY003027), the Applied Basic Research Project in Yunnan Province (grant no. 202201AT070042) and National Key R &D Program of China (grant no. 2022YFC2602500).
Author information
Authors and Affiliations
Contributions
LL and HZ conceived and designed the study. LT, SL and ZL contributed to the data collection and analysis. HZ wrote the manuscript. GL, JL and RM revised the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable
Competing interest
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhong, H., Luo, J., Tang, L. et al. Association filtering and generative adversarial networks for predicting lncRNAassociated disease. BMC Bioinformatics 24, 234 (2023). https://doi.org/10.1186/s1285902305368z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s1285902305368z